Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FELPV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,115.65 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a purchase of pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The award includes no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as the sole prime contractor on this delivery order with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, with a completion date of December 31, 2036. The PPV-G GEN V represents a critical component of the broader $30.3 billion pharmaceutical supply strategy designed to provide military healthcare facilities worldwide with a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and specialty pharmaceuticals. DMS Pharmaceutical Group's established performance across multiple delivery orders and its diverse product portfolio position it as a key regional pharmaceutical supplier supporting recurring medical supply needs of the Department of Defense healthcare system globally.
Quick answers
Who was awarded contract SPE2DU26FELPV?
SPE2DU26FELPV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DU26FELPV worth?
The government has obligated $12,116 on SPE2DU26FELPV.
Is contract SPE2DU26FELPV an order under another contract?
Yes. SPE2DU26FELPV is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELPV competed?
The extent of competition for SPE2DU26FELPV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award